Qube Research & Technologies (QRT)
FOLD

Qube Research & Technologies (QRT)’s Amicus Therapeutics FOLD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$127M Buy
8,809,340
+4,374,661
+99% +$62.7M 0.14% 166
2025
Q4 		$63.1M Buy
4,434,679
+2,685,100
+153% +$26.4M 0.06% 393
2025
Q3 		$13.8M Sell
1,749,579
-1,717,332
-50% -$12.2M 0.01% 1118
2025
Q2 		$19.9M Buy
3,466,911
+2,396,410
+224% +$15.5M 0.02% 885
2025
Q1 		$8.74M Buy
1,070,501
+267,423
+33% +$2.47M 0.01% 1219
2024
Q4 		$7.56M Buy
803,078
+112,160
+16% +$1.17M 0.01% 1263
2024
Q3 		$7.38M Buy
690,918
+629,928
+1,033% +$6.86M 0.01% 1213
2024
Q2 		$605K Sell
60,990
-495,373
-89% -$5.08M ﹤0.01% 2083
2024
Q1 		$6.55M Buy
+556,363
New +$7.12M 0.01% 1065
2023
Q2 		– Sell
-204,119
Closed -$2.26M – 2592
2023
Q1 		$2.26M Buy
204,119
+139,829
+217% +$1.72M 0.01% 954
2022
Q4 		$785K Sell
64,290
-5,779
-8% -$65.1K ﹤0.01% 1322
2022
Q3 		$732K Buy
+70,069
New +$781K ﹤0.01% 1317
2021
Q4 		– Sell
-35,568
Closed -$340K – 2666
2021
Q3 		$340K Buy
35,568
+21,119
+146% +$216K ﹤0.01% 1431
2021
Q2 		$139K Sell
14,449
-11,690
-45% -$114K ﹤0.01% 1878
2021
Q1 		$258K Buy
+26,139
New +$405K ﹤0.01% 1530
2020
Q4 		– Sell
-30,658
Closed -$433K – 1943
2020
Q3 		$433K Buy
30,658
+20,344
+197% +$297K 0.01% 1097
2020
Q2 		$156K Buy
+10,314
New +$126K ﹤0.01% 1462

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FOLD Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Amicus Therapeutics (FOLD) stake by 99% in Q1 2026, buying an estimated $62.7M and bringing the position to 8,809,340 shares worth $127M. The position accounts for 0.14% of the portfolio, ranked #166.

Qube Research & Technologies (QRT) first reported a position in FOLD in Q2 2020 and has held it in 17 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Qube Research & Technologies (QRT) held 8,809,340 shares of Amicus Therapeutics worth $127M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 4,374,661 Amicus Therapeutics shares in Q1 2026, an estimated $62.7M.
  • Amicus Therapeutics made up 0.14% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #166 holding.
  • Qube Research & Technologies (QRT) first reported a position in Amicus Therapeutics in Q2 2020 and has held it in 17 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.